Molecular-genetic mechanisms of initiation, promotion and progression of tumors

Carcinogenesis - the process of turning a normal cell into a tumor cell under the influence of the mutations that accumulate in the cell. The cause of tumor cells is the accumulation of her mutation. The accumulation of cell mutations occurs as a result of the occurrence of genetic instability. The process of tumor development is divided into 3 main stages: initiation, promotion and progression. At the stage of initiation of cell receives the first mutational hit, which leads to disruption of its genetic stability. Most often, mutations are subjected to proto-oncogenes, genes-tumor suppressors, and genes governing DNA repair processes. At this stage there is an accumulation in the cell genetic damage that lead to an increase of the degree of malignancy. The next step in the transformation of cells in a tumor is promoted. This period has transformed as a result of mutations cells acquire a number of properties that help it to survive in the environment. They no longer respond to signals from the environment, acquire, auto- and paracrine stimulation signals of proliferation, the inhibition of apoptosis, genetic instability, changes in the morphology of the cells, the lack of replicative aging. Cells of tumour clone is constantly mutating under the pressure of selection by the immune system of the body. This leads to qualitative changes of the phenotype of tumor cells, the emergence is one of many tumor clones. This stage is called “tumor progression”. As a result of increasing tumor mass requires greater amount of nutrients. The stimulation of angiogenesis. By reducing the degree of affinity of the cells to the substrate and increase its mobility, there are secondary foci, metastases. The development of tumor process captures new areas in the body in Spite of the constant improvement of methods of therapy of tumors, the number of patients who achieve long-term remission is not great. So researchers are looking for ways for more complete and in-depth study of the pathogenesis of tumors, since this will facilitate the development of more effective approaches to therapy of tumors. This article briefly describes the main stages of tumor development.

экспрессия, протоонкоген, ген-супрессор, мутация, канцерогенез, expression, proto-oncogene, gene-suppressor, mutation, carcinogenesis

1. Копнин Б.П. Основные свойства неопластической клетки и базовые механизмы их возникновения. В кн.: Канцерогенез. Под. ред. Д.Г. Заридзе. М.: Медицина, 2004. С. 86-94, 97- 101, 134, 150-152.

2. Alitaio К., Schwab M. Oncogene amplification in tumor cells. Adv Cancer Res 1986; 47: 235-81. PMID: 3022564.

3. Melani C., Rivoltini L., Parmiani G. et al. Inhibition of proliferation by c-myb antisense oligodeoxynucleotides in colon adenocarcinoma cell lines that express c-myb. Cancer Res 1991; 51(11): 2897- 901. PMID: 2032228.

4. Sullivan N.F., Willis A.E., Moore J.P. et al. High levels of the c-myc protein in cell lines of Bloom’s syndrome origin. Oncogene 1989; 4(12): 1509-11. PMID: 2687770.

5. Tesch H., Michels M., Jucker M. et al. Heterogeneous expression of c-myb protein in human leukemia detected by simultaneous two color flow cytometric analysis. Leukemia Res 1992; 16(3): 265-74. PMID: 1560675.

6. Weiss R.A., Schulz T.F. Transforming properties of the HTLV-I tax gene. Cancer Cells 1990; 2(8-9): 281-3. PMID: 2223390.

7. Croce C.M. Role of chromosome translocations in human neoplasia. Cell 1987; 49(2): 155-6. PMID: 3494520.

8. Татосян А.Г., Зуева Э.Ш. Механизмы активации онкогенов. В кн.: Клиническая онкогематология. Руководство для врачей. Под ред. М.А. Волковой. М.: Медицина, 2001. 576 c.

9. Levine A.J. The genetic origins of neoplasia. JAMA 1995; 273(7): 592. PMID: 7837394.

10. Sherr C.J. Tumor surveillance via the ARF-p53 pathway. Cenes Dev 1998; 12(19): 2984-92. PMID: 9765200.

11. Kinzler K.W., Vogelstein В. Cancer therapy meets p53. N Engl J Med 1994; 331(1): 49-50. DOI: 10.1056/ NEJM199407073310113. PMID: 8202105.

12. Knudsen A.G., Strong L.C., Anderson D.E. Heredity and cancer in man. Prog Med Genet 1973; 9: 113-58. PMID: 4351406.

13. Levine A.J. The tumor suppressor genes. Ann Rev Biochen 1993; 62: 623-51. DOI: 10.1146/annurev.bi.62.070193.003203. PMID: 8394683.

14. Ко L.J., Prives K. p53: puzzle and paradigm. Genes Dev 1996; 10(9): 1054-72. PMID: 8654922.

15. Sourvinos G., Tsatsanis C., Spandidos D.A. Mechanisms of retrovirus-induced oncogenesis. Folia Biol (Praha) 2000; 46(6): 226-32. PMID: 11140855.

16. Singerland J.M., Minden M.D., Benchimol S. Mutation of the p53 gene in human acute myelogenous leukemia. Blood 1991; 77(7): 1500-7. PMID: 2009369.

17. Sankar M., Tanaka K., Kumaralev T.S. et al. Identification of a commonly deleted region at 17p13.3 in leukemia and lymphoma associated with 17p abnormality Leukemia 1998; 12(4): 510-6. PMID: 9557609.

18. Weinbeirg R.A. The retinoblastoma protein and cell cycle control. Cell 1995; 81(3): 323-30. PMID: 7736585.

19. Антоненкова Н.Н., Аверкин Ю.И., Белоцерковский И.В. и др. Канцерогенез. В кн.: Онкология. Под. ред. И.В. Залуцкого. Минск: Вышэйшая школа, 2007. С. 45-46.

20. Горбань В.А. Особенности опухолевой ткани. В кн.: Ю.В. Быць, Г.М. Бутенко, А.И. Гоженко и др. Патофизиология. Киев: ВСИ «Медицина», 2015. С. 388.

21. Koebel C.M., Vermi W., Swann J.B. et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature 2007; 450(7171): 903-7. DOI: 10.1038/nature06309. PMID: 18026089.

22. Grivennikov S.I., Greten F.R., Karin M. Immunity, inflammation, and cancer. Cell 2010; 140(6): 883-99. DOI: 10.1016/j.cell.2010.01.025. PMID: 20303878.

23. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J Clin Invest 2009; 119(6): 1420-8. DOI: 10.1172/JCI39104. PMID: 19487818.

24. Joyce J.A., Pollard J.W. Microenvironmental regulation of metastasis. Nat Rev Cancer 2009; 9(4): 239-52. DOI: 10.1038/nrc2618. PMID: 19279573.

25. Polyak K., Weinberg R.A. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 2009; 9(4): 265-73. DOI: 10.1038/nrc2620. PMID: 19262571.

26. Kaplan R.N., Riba R.D., Zacharoulis S. et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005; 438(7069): 820-7. DOI: 10.1038/nature04186. PMID: 16341007.

27. Kim S., Takahashi H., Lin W.W. et al. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 2009; 457(7225): 102-6. DOI: 10.1038/nature07623. PMID: 19122641.

28. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14(6): 818-29. DOI: 10.1016/j.devcel.2008.05.009. PMID: 18539112.

29. Luo J.L., Maeda S., Hsu L.C. et al. Inhibition of NF-kB in cancer cells converts inflammation-induced tumor growth mediated by TNF-a to TRAIL-mediated tumor regression. Cancer Cell 2004; 6(3): 297-305. DOI: 10.1016/j.ccr.2004.08.012. PMID: 15380520.

30. Nguyen D.X., Bos P.D., Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer 2009; 9(4): 274-28. DOI: 10.1038/ nrc2622. PMID: 19308067.

31. Condeelis J., Pollard J.W. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124(2): 263-6. DOI: 10.1016/j.cell.2006.01.007. PMID: 16439202.

32. Galon J., Costes A., Sanchez-Cabo F. et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006; 313(5795): 1960-4. DOI: 10.1126/ science.1129139. PMID: 17008531.

33. Pages F., Berger A., Camus M. et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 2005; 353(25): 2654-66. DOI: 10.1056/NEJMoa051424. PMID: 16371631.

34. Palumbo J.S., Talmage K.E., Massari J.V. et al. Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and -independent mechanisms. Blood 2007; 110(1): 133-41. DOI: 10.1182/blood-2007-01-065995. PMID: 17371949.

35. Mantovani A., Allavena P., Sica A., Balkwill F. Cancer-related inflammation. Nature 2008; 454(7203): 436-44. DOI: 10.1038/nature07205. PMID: 18650914.